复星医药公告,截至2025年7月7日,募投实施主体已将用于暂时补充流动资金的4.1亿元全部归还至募集资金专项账户,并通知保荐机构及代表人。
Source Link复星医药公告,截至2025年7月7日,募投实施主体已将用于暂时补充流动资金的4.1亿元全部归还至募集资金专项账户,并通知保荐机构及代表人。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.